Craft

Cogentix Medical

Stock Price

$4.9

2022-08-04

Market Capitalization

$327.3 M

2022-08-04

Revenue

$56.3 M

FY, 2017

Cogentix Medical Summary

Company Summary

Overview
Cogentix Medical is a medical device company that designs, develops, manufactures, and markets a line of fiber optic and video endoscopy products under the PrimeSight brand that are used in diagnostic and treatment procedures. It also offers the Urgent PC Neuromodulation System, a device that delivers percutaneous tibial nerve stimulation for the office-based treatment of overactive bladder, as well as Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence.
Type
Public
Status
Closed
Founded
1987
HQ
Minnetonka, MN, US | view all locations
Website
http://www.cogentixmedical.com/
Cybersecurity rating
Sectors

LocationsView all

5 locations detected

  • Minnetonka, MN HQ

    United States

    5420 Feltl Rd

  • Orangeburg, NY

    United States

    40 Ramland Rd

  • Westborough, MA

    United States

    135 Flanders Rd

  • Geleen, Limburg

    Netherlands

    2 Hofkamp

  • Wythenshawe, England

    United Kingdom

    3000 Aviator Way

Cogentix Medical Financials

Summary Financials

Revenue (FY, 2017)
$56.3M
Gross profit (FY, 2017)
$37.4M
Net income (FY, 2017)
($882.8K)
Cash (FY, 2017)
$20.9M
EBIT (FY, 2017)
($889.5K)

Footer menu